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Abstract 
PROLONGED STATUS EPILEPTICUS RESULTS IN INCREASED PROTEIN 
KINASE A ACTIVITY IN THE RAT PILOCARPINE MODEL 
By James McLeod Bracey, M.S. 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University 
Virginia Commonwealth University, 2005 
Major Director: Dr. Severn B. Churn 
Associate Professor Departments of Anatomy and Neurobiology, 
Pharmacology and Toxicology, and Physiology 
Director, Molecular Neuroscience Research Facility 
This study was conducted to characterize cellular changes occurring during the 
progression of status epilepticus (SE) that could lead to the maintenance of increased 
membrane excitability. SE was induced by injection of pilocarpine after which rats were 
monitored both electrographically and behaviorally. After various lengths of time in SE, 
specific brain regions were isolated for biochemical study. SE resulted in an early 
vii 
maintenance of PKA activity in both cortical homogenate and crude synaptoplasmic 
membrane (crude SPM) fractions. At subsequent stages of SE there was a significant 
increase in PKA activity in both homogenate and crude SPM fractions. Wester blot 
analysis showed that alteration of PKA protein expression was not responsible for the 
increase in PKA activity. These results show that SE has a significant duration- 
dependent effect on PKA activity. Combined with other cellular changes these findings, 
could represent a mechanism for the formation for potentiated seizure states like epilepsy. 
INTRODUCTION 
Epilepsy 
Epilepsy is a common neurological disorder experienced by roughly 2.5 million 
people in the United States alone with greater than 150,000 people developing seizures 
and/or epilepsy each year. Overall, epilepsy occurs when there is an imbalance in 
signaling contribution between excitatory and inhibitory neurons. This imbalance leads 
to excessive excitatory signaling through an increase in glutamatergic (excitatory) 
responses, decreased y-aminobutyric acid ([GABAIergic) inhibitory responses, or 
possibly a combination of the two. Seizure activity is commonly attributed to a decrease 
in the inhibitory effects of GABA receptor mediated channels. Under normal physiologic 
conditions, GABA channels allow for the conductance of negatively charged chloride 
ions into the cell which counterbalance the effects of incoming positive ions associated 
with glutamatergic channels. This influx of chloride helps maintain the cell's normal 
electrical activity and membrane potential. When the GABA channel is somehow 
altered, the normally occurring inhibition it provides is lost resulting in an over excitation 
of the cell. 
In epilepsy, most seizures are relatively short lived and end through a process of 
self termination. There are some pathologies that result in seizures that do not self- 
terminate but progress into a neurological insult known as status epilepticus (SE). It is 
possible that seizures that are capable of self-termination do so through the effects of 
GABA-receptor mediated inhibition and that the inhibitory currents associated with these 
channels is the source of the seizure termination. Hosts of studies into antiepileptic drugs 
(AEDs) including, but not limited to, benzodiazepines, diazepam, lorazepam and 
barbiturates, have shown that these drugs target GABAA receptors. These drugs work by 
enhancing the receptor-mediated inhibition through increased conductance through these 
channels. This suggests that these channels are intimately involved in the process of 
seizure termination. 
Status Epilepticus 
SE is generally defined as a seizure, either single or in an intermittent series, 
which lasts at least 30 minutes during which time the patient does not regain 
consciousness (Bassin et al. 2002). A more current definition states that SE is 
characterized by a continuous, generalized, convulsive seizure lasting greater than 5 
minutes or two or more seizures during which the patient does not regain consciousness 
(Bassin et al. 2002; Lowenstein et al. 1999; Treiman et al. 1998). This shorter time 
window is supported by the fact that both clinically and experimentally, AEDs lose their 
efficacy over time as SE duration increases. Frontline AEDs must therefore be given as 
early as possible during the course of SE to ensure effectiveness. 
SE is a highly common neurological emergency affecting greater than 100,000 
individuals every year in the United States. SE is also a major medical emergency with a 
mortality rate of greater than 20% attributed primarily to anoxia, prolonged seizure and 
advanced age (DeLorenzo et al. 1996). It has also been shown that patients with epilepsy 
have a two to three fold greater chance of mortality when compared to the general 
population (Tomson 2000). 
Prolonged and uninhibited excitation causes severe and irreversible damage in 
neuronal structures in a variety of pathologies such as cerebral ischemia, Alzheimer's 
disease, amyotrophic lateral sclerosis and seizure disorders (Anzai et al. 2003; Blennow 
et al. 1978; Butterfield and Boyd-Kimball2005; Carriedo et al. 2000; Sankar et al. 1998), 
a process called excitotoxicity. These same types of effectstare seen in SE as well with 
neuropathological changes induced by the seizures being confined to those locations 
experiencing excessive excitation. In addition, many proteins important for proper 
neuronal function have been shown to be affected by SE, including calciumlcalmodulin 
dependent protein kinase I1 (CaMKII) (Churn et al. 2000) and protein phosphatase 2B or 
calcineurin (CaN) (Kurz et al. 2001). 
Cyclic-AMP dependent Protein Kinase A 
Another protein of interest is cyclic-AMP dependent protein kinase (PKA). PKA, 
a member of the serinelthreonine kinase family, is ubiquitously expressed and mediates 
both intracellular signal transduction and intercellular signal transmission (Nguyen and 
Woo 2003). PKA is a heteromultimer composed of two regulatory subunits and two 
catalytic subunits. When cyclic-AMP (CAMP) binds to the regulatory subunits, the 
catalytic subunits are released activating the enzyme leading to the phosphorylation of 
endogenous substrates. This enzyme activation can then be maintained through several 
mechanisms such as the ubiquitination of the regulatory subunits or phosphorylation of 
the regulatory subunit by the catalytic subunit causing the two to have a decreased 
binding affinity. This decrease in subunit ratio or binding affinity results in sustained 
kinase activity. 
Previous studies have shown that high frequency stimulation of synaptic pathways 
in the hippocampus can increase cAMP levels thus activating PKA (Chetkovich et al. 
/ 
1991). In addition, adenylate cyclases have been shown to be activated by the Dl 
subtype of dopamine receptor resulting in increased cAMP formation (Barone et al. 
1990). This increase in cAMP would also have the effect of stimulating PKA. 
Activation of PKA has been shown to be important for a variety of neuronal functions 
notably in the formation of late stages of long-term potentiation (LTP). Progression into 
late-LTP has the effect of changing synaptic systems from learning acquisition to 
memory consolidation. PKA facilitates this through increased ion channel function 
(Crump et al. 2001; Esteban et al. 2003; Meuth et al. 2002) and new protein synthesis, 
among others (Kang and Schuman 1996; Krug et al. 1984; Otani et al. 1989). 
The Rat Pilocarpine Model of SE 
A variety of models of SE are used, including anti-GABA drugs, glutamatergic 
drugs, cholinergic drugs and electrical stimulation (Churn et al. 2000). Damage from 
each of these models is similar and indicates that the pathological effects are not model 
specific, but due to seizure activity associated with SE. In the following study, the 
pilocarpine (pilo) model was used for SE induction in rats. Pilocarpine is a muscarinic 
agonist and mimics the action of acetylcholine. Prior to pilocarpine injection, 
methylscopolamine, a muscarinic antagonist, is injected to reduce the peripheral, adverse 
effects of pilocarpine. A short time following the injection of pilo, discrete seizure 
activity can usually be noticed. Typically within 8 to 12 minutes following the onset of 
discrete seizure activity, non-terminating seizure activity is noticed. This is defined as 
the onset of SE. 
This research focuses on the effects of SE on PKA activity. This study was 
conducted to characterize the relationship between PKA activity and SE progression over 
time. SE was induced in adult rats and allowed to continue for predetermined times up to 
and including one hour of SE activity. Electroencephalographic (EEG) recordings were 
made throughout each experiment after which, animals were sacrificed and biochemical 
assays were performed. EEG was analyzed for total time in SE and time to the start of 
each SE phase. In addition to EEG recordings, biochemical assays were performed to 
determine if there is an SE duration dependent change in PKA activity. The data suggest 
that there is a delayed duration dependent increase in PKA activity seen in the cortex 
during SE. This is in concert with the decrease in CaMKII activity seen immediately 
upon the induction and the delayed increase in CaN activity seen during SE progression. 
The following chapter is a paper that has been submitted for publication in Neurobiology 
of Disease. The paper is formatted according to the guidelines set by the journal in 
which it will appear. 
STATUS EPILEPTICUS RESULTS IN A DURATION-DEPENDENT 
INCREASE OF PROTEIN KINASE A ACTIVITY IN THE RAT 
PILOCARPINE MODEL 
ABSTRACT 
This study characterized the effects of status epilepticus (SE) on PKA activity in 
the rat pilocarpine model. SE was induced and seizure activity was monitored 
electrographically and cellular changes studied biochemically. PKA activity in whole 
tissue homogenates as well as crude synaptoplasmic membrane fractions was assessed 
through substrate phosphorylation reactions. No significant changes in PKA activity 
were observed during early stages of SE. However, as SE progressed, significant 
increases in both total and synaptic PKA activity were observed. In addition, there was 
no observed increase in PKA protein expression in either homogenate or synaptic 
samples. Because increased PKA and other protein kinase activities are associated with 
long-term potentiation (LTP), increased PKA activity during SE could result in 
maintained potentiation of large numbers of synapses on a whole-brain level. These data 
support the hypothesis that PKA plays a role in the progression of SE and possibly in the 
process of epileptogenesis 
INTRODUCTION 
Status Epilepticus (SE) is a life threatening emergency that affects approximately 
100,000-150,000 people per year (Bassin et al. 2002; DeLorenzo et al. 1996; Fountain 
2000; Goodkin et al. 2003) and has a significant mortality rate (Bassin et al. 2002; 
Tomson 2000; Waterhouse et al. 1998). SE is defined as either a continuous seizure 
lasting 230 minutes or continuous recurrent seizures without the recovery of 
consciousness (Fountain 2000). The definition has been modified in recent years to say 
that, in adults and children over 5 years of age, SE should be considered after 25 minutes 
of continuous seizure activity or two or more individual seizures between which there is 
an incon~plete recovery to consciousness (Lowenstein and Alldredge 1998; Lowenstein et 
al. 1999). This revised definition takes into consideration the fact that most tonic clonic 
seizures self-terminate within a 5 minute window (Theodore et al. 1994). In addition, SE 
results in several secondary effects such as the loss of efficacy of seizure suppressing 
drugs, including benzodiazepines, with prolonged seizure episodes and the development 
of spontaneous recurrent seizures through a process known as epileptogenesis. This 
observation suggests that as seizure activity progresses, cellular changes occur that 
change neuronal physiology. Therefore, understanding the cellular changes that occur 
during SE may elucidate the processes that result in epileptogenesis. 
Cyclic-AMP dependent Protein Kinase A (PKA) is a ubiquitously expressed 
member of the serine-threonine kinase family and is known to mediate intracellular signal 
transduction in a variety of animal systems. Notably, PKA has been associated with 
mediation of both short-term synaptic facilitation via reversible phosphorylation of ion 
channels as well as long-term facilitation through modulation of gene expression and 
protein synthesis (Bailey and Kandel 1993; Hawkins et al. 1993; Kandel2001). PKA has 
been shown to affect both excitatory and inhibitory neuronal signaling and exhibits 
complementary as well as antagonistic modulatory effects with respect to 
calcium/calmodulin dependent protein kinase I1 (CaMKII) and protein phosphatase 2B or 
calcineurin (CaN). For example, PKA has been shown to both enhance and inhibit 
GABAA receptor currents (Kapur and Macdonald 1996; McDonald and Moss 1997) 
while the action of CaMKII increases agonist-evoked inhibitory currents (Churn and 
DeLorenzo 1998; Churn et al. 2002; Kapur and Macdonald 1996; Wang et al. 1995; Wei 
et al. 2004) as well as increases conduction through excitatory glutamate receptors (Fink 
and Meyer 2002; Poncer et al. 2002; Wang and Kelly 2001). In addition, PKA has been 
shown to have an inhibitory effect on protein phosphatase 1 (PPl) activation by CaN 
(Vinade and Dosemeci 2000). PKA has been extensively studied and has been shown to 
have altered expression or activity in a variety of pathologies. For instance, in cerebral 
ischemia models there is a differential activation of PKA and subsequent CREB 
phosphorylation in peri-ischemic and ischemic areas (Tanaka 2001). Disruption of 
hippocampal circuits, used as a model of neuronal reorganization, results in the up- 
regulation of several genes involved in signal transduction including PKA (Anguelova et 
al. 2000). In addition, PKA has been associated with the abnormal tau phosphorylation 
and neurofibrilary tangle formation seen in Alzheimer's disease (Bonkale et al. 1999). 
Despite these findings, little research has been done into PKA's role in status epilepticus. 
This study utilized electrographic and behavioral monitoring in the Pilo-SE model 
and tracked changes in PKA activity during the progression of status epilepticus. 
Following the development of SE, the data show that PKA activity is maintained while in 
later stages of SE, there is a significant increase in PKA activity. The data suggest that 
the modulation of PKA activity is involved in cellular changes associated with prolonged 
seizure activity in SE. 
MATERIALS AND METHODS 
Materials 
All materials were reagent grade and purchased from Sigma Chemical Company 
(St. Louis, MO, USA) and Fisher Scientific (Pittsburgh, PA, USA) unless otherwise 
stated. [ y - 3 2 ~ ] ~ ~ ~  was purchased from Perkin Elmer Life and Analytical Sciences 
(Boston, MA, USA). Adult male Wistar rats were purchased from Harlan Laboratories 
(Indianapolis, IN, USA). SignaTECT PKA assay system components were purchased 
from Promega (Madison, WI, USA). KT-5720 was purchased CalBiochem (San Diego, 
CA, USA). Affinity purified rabbit polyclonal anti-PKAP catalytic subunit was obtained 
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Purified goat polyclonal anti- 
PKA RII subunit and mouse monoclonal anti-P-tubulin (clone AA2) were obtained from 
Upstate (Lake Placid, NY, USA). 
Methods 
Pilocarpine Model of Status Epilepticus 
All animal use procedures were in strict accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals and were approved by the 
Virginia Commonwealth University Institutional Animal Care and Use Committee. 
Wistar rats were handled following arrival from Harlan Laboratories, for acclimation 
prior to drug treatment. One week prior to the induction of SE, 4 surface electrodes were 
implanted into the skull of rats under ketamine anesthesia, as described previously 
(Chum 2005; Singleton et al. 2005b). Two frontal electrodes were implanted over frontal 
cortex [3 Smm ant. Bregma, h2.5mm L/R (F 1/F2)]. Two posterior electrodes were 
implanted over parietal cortex and hippocampus [2.0mm post. Bregma, A2.5mm L R  
(Pl/P2)]. A 5" electrode was fixed onto the surface of the skull as a ground. The 
electrodes were secured in place with dental acrylate and the animals were allowed at 
least 5 days to recover from surgery before experiments were performed. 
Induction of Status Epilepticus 
Control and experimental animals were hooked up to EEG machines (Viking IV, 
Nicolet, Madison, WI) and baseline EEG recordings were obtained for 10 minutes 
following scopolamine injection. 30 minutes prior to the injection of pilocarpine, 
methylscopolamine, a muscarinic antagonist, was administered i.p. (1 mglkg) to reduce 
adverse peripheral affects of the pilocarpine. SE was induced in experimental animals by 
intraperitoneal injection of 375 mglkg pilocarpine HC1 (Pilo), a muscarinic agonist. 
Behavioral and encephalographic activity was recorded throughout the procedure using 
video and EEG recording. Once initial seizure activity was observed, the time was noted 
and rats were allowed to seize for specific amounts of time before the animals were 
processed. These time points consisted of 10,20,40 and 70 minutes post first discrete 
seizure. Since this lab has characterized SE onset as being approximately 10 minutes 
after the first discrete seizure (Singleton et al. 2005b), these times approximate 0, 10, 30 
and 60 minutes of SE, respectively. Electrographic data was analyzed for SE 
susceptibility, number of discrete seizures, death rate, time to first seizure, time from first 
seizure to SE, average duration of SE for each animal, percent of time spent in each stage 
of SE for each animal, and once in SE, seizure severity. Spectral analysis of EEG 
activity was performed using Insight I1 software (Persyst Corporation Prescott, AZ). 
After induction of SE, seizure activity was characterized according to the system of 
Handforth and Treiman (Handforth and Treiman 1995a; Handforth and Treiman 1995b). 
Seizure severity was determined based on the amount of time spent in each stage of SE. 
Behavioral seizures were assessed according to the scale of Racine (Racine 1972). 
Brain Region Isolation 
Brain region isolation was performed as previously described with slight 
modifications (Churn et al. 2000). Specific brain regions (cortex and hippocampus) were 
dissected away on ice and immediately homogenized into an iced-cold buffer containing 
50mM Tris-HC1 (pH 7.4), 7mM EGTA, 5mM EDTA, 320mM sucrose, 1mM 
dithiothreitol (DTT), and 0.3mM phenylmethylsulfonyl fluoride (PMSF). The brain 
regions were homogenized by 10 up and down strokes using a teflon pestle at 12,000 
rpms (Fordham Bethel, CT). A portion of the sample was then aliquoted and frozen at - 
80°C until processed for biochemical analysis. 
Isolation of Subcellular Fractions 
Subcellular fractions were isolated by a differential centrifugation procedure as 
modified from Edelman et al. (Edelman et al. 1985). Brain region homogenates were 
centrifuged at 5,000 x g for 10 min (Beckrnan JA-17 rotor) to produce a crude nuclear 
pellet (PI). The supernatant from the spin (Sl) was then centrifuged for 30 min at 18,000 
x g to produce a crude synaptoplasmic membrane/mitochondrial pellet (crude SPM), 
which was resuspended in homogenization buffer. All fractions were rapidly separated 
into aliquots and stored at -80°C for later use. 
Substrate Phosphorylation 
Brain region homogenates and crude SPM fractions were normalized for protein 
concentration using the Bradford method with BSA as the standard (Bradford 1976). 
PKA dependent phosphorylation reactions contained sample (1 50 pg), PKA Assay Buffer 
5X, [y-32PlATP in 0.5mM ATP, PKA Biotinylated Peptide Substrate 100mM, *CAMP 
0.025mM, * dH20. ATP mix was made by adding 0.05pL [y-32PlATP ((3,00OCi/mmol) 
IOpCiIpl) to 0.5mM cold ATP (5p1) per reaction. Final volume of all reaction tubes was 
25pL. Following inclusion of PKA buffer, PKA substrate, dHzO for basal reactions or 
CAMP for maximal reactions, [y-32PlATP (5pL) was added and the reaction tubes 
allowed to incubate in a 30' C water bath for 5 minutes. After 5 minutes 5pL of protein 
sample was added to each tube. Tubes were then allowed to incubate in a 30°C water 
bath for an additional 5 minutes. The reactions were then stopped via the addition of 
7.5M guanidine hydrochloride (12.5pL). Basal and maximally stimulated reactions were 
performed in triplicate. 1 OpL aliquots were then taken from each tube and spotted on a 
biotin capture membrane. Membranes were then washed to remove unbound phosphates. 
Washes were as follows: Four washes in 2M NaC1,4 washes in 2M NaCl with 1% 
&Po4 and 2 washes in deionized water. Following drying the biotin membrane sections 
were placed in scintillation vials, 2ml of cytoscint was added and the reactions were 
counted using a Beckrnan LS 2800 scintillation counter. 
Immunodetection of PKA Regulatory and Catalytic subunits 
Western analysis was performed to quantify the protein levels of PKA regulatory and 
catalytic subunits essentially as described previously (Churn et al. 1995; Churn et al. 
1992; Singleton et al. 2005b). Briefly, homogenate and crude synaptic cortical and 
hippocampal fractions were resolved on SDS-PAGE and transferred to a nitrocellulose 
membrane using the Trans-blot system (Bio-Rad, Hercules, CA, USA). The 
nitrocellulose membranes were then immersed for 1 h in blocking solution containing 
phosphate-buffered saline (PBS, pH 7.4), 0.05% (vlv) polyoxyethylene sorbitan 
monolaurate (Tween-20), 50 g/L Bio-Rad blotting grade dry milk, and horse serum 
(Vector Laboratories Inc., diluted 50 mLI10 mL). The nitrocellulose membranes were 
then incubated with primary antibody in blocking solution at 4OC overnight. Primary 
antibodies were diluted 1 : 1000 in PBS with Tween-20 and 50g/L nonfat dry milk. 
Membranes were washed three times in a wash solution containing PBS and Tween-20. 
The nitrocellulose membranes were then reacted with an appropriate secondary antibody 
(1:5000) in blocking solution for 1 hour. Nitrocellulose was then washed three times in 
PBS for 10 min per wash. Blots were developed using ECL dectection (Pierce, 
Rockford, IL). Chemiluminescence was detected by using Kodak autoradiographic film. 
Specific immunoreactive bands were quantified by computer-assisted densitometry using 
a BioRad GS-800 calibrated densitometer and the BioRad Quantity One software 
(Version 4.4.0) as described previously (Churn et al. 2000; Singleton et al. 2005b). As a 
protein loading control, western blot membranes were probed with an anti-P-tubulin 
antibody (1 : 1000). 
Statistical Analysis 
Data was analyzed using GraphPad Prism version 4.0 (GraphPad Software, San Diego, 
CA USA). Student's t tests were used for all single, parametric comparisons. For 
multiple comparisons, one-way ANOVA with a Tukey post hoc analysis with 95% 
confidence was used. 
RESULTS 
Time-dependence of Pilo-induced SE 
Monitoring of SE phases was performed through electrographic and video 
recordings (see Materials and Methods). Baseline electrographic recordings were 
obtained following injection of scopolamine with activity consisting of low amplitude, 
asynchronous spikes. Approximately 20 minutes after pilocarpine injection, 
electrographic activity slowed and amplitude increased finally culminating in overt ictal 
activity (Figure 1A). During seizure induction baseline data gave way to anincrease in 
amplitude and decrease in frequency. Spectral analysis of ictal activity during the first 
discrete seizure indicated a near 10-fold increase in the delta component. This denoted 
the onset of the discrete seizure phase. A typical seizure progression was observed as 
reported previously including behavioral manifestations of decreased ambulation, 
uncontrolled salivation, tonic/clonic movements, rearing and falling and myoclonus 
(Singleton et al. 2005b). These characteristics represent behavioral scores of between 1 
and 4 on the Racine scale (Racine 1972). Each discrete seizure was characterized by a 
gradual increase in electrographic activity which peaked for 10-40 seconds. This was 
followed by a sudden drop back to baseline levels (Singleton et al. 2005b). Typically, 
pilocarpine treated rats developed 2-3 discrete seizures lasting 20-50 seconds each. A 
small population of animals displayed discrete seizure activity but did not develop overt 
SE (Sz-NOSE). These animals were separated and used as a No-SE surgery control group 
as described before (Singleton et al. 2005a). 
In animals that developed SE, EEG activity for each animal was analyzed for all 
SE seizure stages including WaxIWane ( W N )  (Figure 1 B), FastlSlow (FIS) (Figure 1 C), 
Early Continuous (EC) (Figure 1D) and Fast Spiking with Pauses (FSIP) (Figure lE), as 
described (Singleton et al. 2005b). EEG from pilocarpine treated rats, experiencing 10 
minutes to over one hour of time spent in SE, was reviewed and the times to the start of 
each seizure phase listed above were determined. Time to start of each seizure phase was 
calculated using the initiation of the first discrete seizure asdime zero (Singleton et al. 
2005b). Times for all rats were averaged together since the time each rat was sacrificed 
has no direct bearing on what seizure phase was entered. The average time for rats to 
enter WIW was 6 minutes 23 seconds (k 69 sec). The average time to the start of FIS was 
10 minutes 57 seconds (h 79 sec). This average was slightly skewed due to the fact that 
one rat entered FIS prior to entering the WIW phase and did so only 41 seconds following 
the start of the first discrete seizure. Removing this data yielded a new average of 12 
minutes 45 seconds to the onset of FIS. 
Following the FastISlow period there was a significant decrease in the numbers of 
animals reaching later stages of SE. Animals that entered EIC did so in an average of 19 
minutes 30 seconds (k 3 min. 5 sec. sec). Further, the animals that entered F S P  did so in 
an average of 28 minutes 34 seconds (* 4min. 42sec.). These data show that, as SE 
seizure activity progresses, there is a positive correlation between length of time in SE 
and seizure phase attained. 
SE-induced Activation of CAMP -dependent Protein Kinase 
Maintenance of PKA Activity during SE in cortical and hippocampal homogenate 
PKA activity during specific durations of status epilepticus was assessed in whole 
tissue homogenates using an exogenous substrate (Figure 2). Rats were allowed to seize 
for predetermined periods of time after which the cortex and hippocampus were isolated, 
homogenized and used to test for PKA activity through a substrate phosphorylation 
procedure (see Materials and Methods). 
The basal activity level of PKA in control cortical homogenates was 
approximately 0.034 pmol P04/pg protein (n=9) (Figure 2A). Under maximally 
stimulated conditions control cortical samples showed a roughly ten-fold increase in PKA 
activity, 0.30 pmol P04/pg protein (n=9) (Figure 2A). To confirm the specificity of the 
assay for measuring PKA activity we included KT-5720, a specific inhibitor of PKA, into 
parallel reaction vessels. Using control homogenate samples the inhibitor was added 
with its final concentration equaling 10 pM. Treatment of these samples produced 
significant decreases in both basal and maximally treated reactions (data not shown). 
SE did not modulate basal PKA activity at any time point studied (Figure 2A). 
However, SE did result in altered maximal basal activity. Samples from animals 
experiencing 10 minutes of SE were observed to have roughly the same level of activity 
as is found in control samples (0.335 pmol P04/pg protein (p0 .05,  One-way ANOVA)). 
In 20-minute animals, the maximal PKA activity was approximately 0.441 pmol P04/pg 
protein. While this is an increase of about 37%, it was not statistically significant when 
compared to control levels (n=8, p>0.05). Later in the progression of SE, maximal levels 
of PKA activity continue to remain higher than controls with 40-minute sample maximal 
PKA activity roughly 0.399 pmol P04/pg protein (33% increase) (n=6, p>0.05). The 
level of activity seen in 70-minute samples was observed to be approximately 0.46 pmol 
P04/pg protein, a 53% increase that was significantly different when compared to control 
samples (n=6, p<0.001). The data were also compared with data from animals that had 
discrete seizures but did not go into status epilepticus (Sz-NOSE). Sz-NOSE animals had 
maximal PKA activity levels of roughly 0.26 pmol P04/pg protein, a 14% decrease but 
not significantly different from control animals (n=6, pB0.05). This is analogous to the 
previous findings that CaMKII activity does not change in animals displaying discrete 
seizures but not entering SE (Singleton et al. 2005a). 
Hippocampal homogenates were examined for PKA,activity as described above 
(Figure 2B). Basal PKA activity in the hippocampal homogenate samples was 0.006 
pmol P04/pg protein (n=lO). Maximally stimulated activity was approximately 4-fold 
higher than basal activity (0.021 pmol P04/pg protein) and was significantly different 
when compared to the basal reaction activity levels (n=10, p<0.001). Basal levels of 
PKA activity were not significantly different between control samples and any of the 
time points studied (n=39, p>0.05). As was observed in the cortical samples, maximal 
PKA activity was maintained over the early 10 and 20-minute time points (n=6, 0.022 
pmol P04/pg protein and n=7, 0.022 pmol P04/pg protein, respectively, p>0.05). 
Samples from animals experiencing 40 and 70 minutes of SE showed slight increases in 
PKA activity when compared to control animals with 40-minute samples having maximal 
PKA activity levels around 0.024 pmol P04/pg protein and 70-minute samples PKA 
activity around 0.025 pmol P04/pg protein. Neither time point showed a significant 
change when compared to control samples (n=6 and n=6 respectively, p>0.05). Similar 
to the data observed for cortical homogenates, hippocampal samples from Sz-NOSE 
animals showed no significant change in maximal PKA activity when compared to 
control values (0.016 pmol P04/pg protein, n=4, p>0.05). 
Immunodetection of PKA levels in cortex and hippocampus homogenate 
A possible mechanism to modulate PKA activity can be accomplished through an 
increased enzyme expression or change in relative expression levels of regulatory subunit 
versus catalytic subunit. To determine whether the observed increase in PKA activity 
seen in whole cell homogenates was due to an increase in PKA protein levels or relative 
decrease in regulatory subunits versus catalytic subunits, western analysis was performed 
on whole cell homogenates fiom the cortex and hippocampus utilizing commercially 
available antibodies towards both the catalytic and regulatory subunits of PKA (see 
Materials and Methods). Control, 20,40 and 70 minute samples were examined to 
determine any changes in protein levels during a time course of SE. When probing for 
PKA catalytic subunits in cortical homogenate (Figure 3 A, B), the relative density for 
control samples was 0.46. The 20-minute relative density was 0.36, a 12% change and 
the 40-and 70-minute relative densities were 0.43 and 0.35 respectively (4.8% and 15% 
changes n=4 each, p>0.05). In hippocampal samples (Figure 4 A, B), similar results were 
obtained. The relative density for control samples was 0.67 and all time points studied 
had optical densities of between 0.47 and 0.53. While the differences amounted to 
changes of 20-30% none were significant when compared to either control or each other 
(n=4 each, p>0.05). Thus, the net increase in PKA activity could not be explained by an 
increase in catalytic subunit expression. 
To determine if a selective loss of PKA regulatory subunit could explain the 
apparent increase in activity, total subunit protein levels were assessed. In cortical 
homogenates (Figure 3 C, D), control samples had an average optical density of 1.54 
while 20-minute samples had an optical density of 1.59,40-minute samples 1.69 and 70- 
minute samples had an optical density of 1 SO. No cortical homogenate samples 
displayed a density that was significantly different when compared to either control or 
each other (n=16, p>0.05). Probing for PKA regulatory subunits in hippocampal 
homogenates also displayed results similar to those seen for the catalytic subunits (Figure 
4 C, D). Control samples had an average optical density of 2.21 while 20,40 and 70- 
minute samples had optical densities of 1.91, 1.85 and 1.70 respectively. These represent 
decreases of between 14% and 24% but were not statistically significant when compared 
to control levels or each other (n=16, p>0.05). Thus, altered catalytic subunit protein 
expression was not the primary mechanism to increase PKA activity. 
Maintenance of PKA activity during SE in cortical and hi~pocampal brain subcellular 
fractions 
Due to the early maintenance and subsequent increase of PKA activity on the 
whole cell homogenate level, we wanted to determine if there were any selective changes 
in PKA activity in the crude synaptic membrane fraction. Subcellular fractions were 
made from brain homogenates including those for 10,20,40 and 70 minute samples post 
first discrete seizure (See Materials and Methods). Basal levels of PKA activity in the 
cortical crude SPM samples was approximately 0.004 pmol P04/pg protein (Figure 5A), 
a significantly lower level when compared to homogenate samples. Control maximal 
levels of PKA activity were 0.02 pmol P04/pg protein, a five-fold increase over the basal 
samples (n=6, p<0.001). Again, basal levels of PKA activity for all time points tested 
were not significantly different when compared to control values (n=32, p>0.05). 
Similar to the observations made in the cortical homogenate, PKA activity levels 
were maintained during the initial phases of SE progression. Samples from 10-minute 
animals had maximal PKA activity levels of 0.01 8 pmol P04/pg protein while 20-minute 
samples had activity levels of 0.0 19 pmol P04/pg protein. Neither of these were 
significant changes when compared to control values. As SE progressed into later stages, 
the crude SPM PKA activity level increased in a manner similar to the homogenate. In 
40-minute samples the maximal PKA activity was 0.034pmol P04/pg protein, a 70% 
increase over the control value (n=6, p<0.05). 70-minute samples had an activity level of 
0.03 1 pmol P04/pg protein (n=6, p>0.05) which was a 55% increase over control. 
Crude SPM fractions from the hippocampus displayed a similar maintenance of 
PKA activity throughout the time course of SE (Figure 5B). Basal levels of PKA activity 
in control hippocampal crude SPM fractions was 0.004 pmol P04/pg protein while 
maximal activity was 0.01 3 pmol P04/pg protein (n=8). Again both levels were 
significantly lower than those seen in homogenate samples. Basal levels for all 
experimental time points were not significantly different from the control value. 
Maximal PKA activity for all time points was not significantly different from the control 
maximal value. The 1 0-minute samples had an activity of 0.0 12 pmol P04/pg protein 
(n=5), 20-minute samples had activity of 0.01 1 pmol P04/pg protein (n=8), 40-minute 
samples had activity of 0.009 pmol P04/pg protein (n=4) and 70-minute samples had 
maximal PKA activity of 0.01 1 pmol P04/pg protein (n=10). Similar to all other 
fractions studied, hippocampal crude SPM samples showed a maintenance of PKA 
activity but without the increase in activity during later stages of SE progression. 
Immunodetection of PKA in subcellular fractions 
Since PKA affects many substrates found in the synapse and has been shown in 
this study to have an increased level of activity in subcellular fractions at later stages of 
SE, it was important to determine if the increased activity was due to a translocation of 
kinase to the synaptic region. Western analysis was performed to determine PKA protein 
levels in the crude SPM fractions at specific time points post first discrete seizure. 
Control, 20,40 and 70-minute samples were used to probe for both catalytic and 
regulatory subunit expression (Figures 6-7). When probing,for catalytic subunits, optical 
density in cortical control crude SPM was 0.69 (Figures 6A, B). Densities for 20 and 70- 
minute time points were roughly the same as control with values of 0.61 and 0.67 
respectively. These changes were only 3% and 12% respectively and were not 
statistically significant (p0.05). The 40-minute samples however, had an average 
optical density of 0.18. This was a decrease of about 75% (p<0.05). 
As was the case for homogenate samples, western blots were probed for PKA 
regulatory subunit expression over the time course of SE progression (figure 6 C, D). 
While optical density values were observed to be lower than those associated with the 
homogenate samples the results obtained were very similar to those for the PKA catalytic 
subunit expression in the same tissue. Control samples had an average optical density of 
0.96 which was equaled by the 20-minute animals which also had an average optical 
density of 0.96. Similar to the PKA catalylic subunit, the optical density for 40-minute 
samples was observed to decrease by about 47% to 0.5 1. This was followed by a return 
near to control levels for the 70-minute samples with an average optical density of 0.82. 
While there is a large decrease at 40-minutes, none of the time points were statistically 
different when compared to either control or each other (n=16, p>0.05). 
Wanting to ensure that these decreases in 40-minute samples were not due to a 
protein loading error, blots were probed for levels of P-tubulin, a neuronal specific 
marker. Average optical density for control samples was 1.23 while those for 20,40 and 
70-minute samples were 1.20, 1.1 1 and 1.13 respectively. None of these were 
statistically significant changes when compared to control samples. (p0 .05,  one-way 
ANOVA) This indicates that the loss of PKA regulatory and catalytic subunits seen after 
40 minutes of SE represents some form of major cellular change in enzyme expression. 
Attempts were made to identify a subcellular pool with an increased level of PKA at 40- 
minutes but no significant changes could be seen. If PKA translocates to the cytosol it is 
possible that PKA native to the cytosol could mask any increase in PKA from the 
synapse. 
Despite having no significant changes in PKA activity, hippocampal crude SPM 
samples were probed for PKA catalytic and regulatory subunit expression levels. When 
probing for catalytic subunits, hippocampal crude SPM fractions displayed results similar 
to those seen in the homogenate san~ples (Figure 7 A, B). Average optical densities for 
control samples and experimental time points were around 1 .O. Control samples had a 
density of 1.06 while 20,40 and 70-minute samples had densities of 1.08, 0.94 and 1.00, 
respectively. These differences from control densities represented changes of between 
1% and 12% only and were not statistically significant. 
When analyzing regulatory subunit expression in the hippocampal fractions, a 
trend similar to that of the cortical samples was observed (Figure 7 C, D). Control 
densities were roughly equal to 0.98. As was noticed in the homogenate, a small 
decrease was observed at 20 minutes with a density of 0.79. A further decrease was seen 
at 40 minutes to a density of 0.64 while the 70-minute samples had a density of 0.85. 
While these differences accounted for changes between 14% and 45%, none were 
statistically significant when compared to controls (n=16, p>0.05). 
Figure 1. Seizure Progression in the Rat Pilo-SE model , 
Typical electrographic progression during SE induction. A) Following 
pilocarpine injection, discrete seizure activity was observed consisting of small increases 
in amplitude over baseline progressing to higher amplitude, lower frequency activity. 
This was followed by an abrupt ending. B) Roughly 7 minutes after observation of the 
first discrete seizure, seizure activity progressed into a waxlwane spike frequency. This 
phase denoted the onset of SE. C) Following waxlwane rats typically entered a fastlslow 
phase within 13 minutes of the start of the first discrete seizure. This phase was 
characterized by high amplitude, high frequency spiking followed by low amplitude, low 
frequency spiking. D) The next phase, early continuous, typically commenced within 2 1 
minutes and was characterized by continuous high frequency, high amplitude spiking. E) 
Fast spiking with pauses was the final phase of SE observed in this population of animals 
and commenced roughly 30 minutes post first discrete seizure. 
Seizure progression in the Rat Pilo-SE model 
Figure 2A. Prolonged SE activity results in increased PMA activity in cortical 
homogenates. 
Cortical homogenates were studied for basal (white bars) and maximally 
stimulated kinase activity (black bars) in control, 10,20,40 and 70-minute animals post 
first discrete seizure. In all samples, a statistically significant CAMP-induced PKA 
activity was observed compared to basal phosphorylation levels (p<0.001, one-way 
ANOVA). There was no SE-induced effect on basal PKA activity at any time point 
studied. Kinase activity in cortical homogenates was not significantly different from 
control during the early 10 and 20-minute time points of SE. An increasing trend was 
observed between 20,40 and 70-minute animals with the 70-minute samples displaying a 
53% increase in maximal activity. PKA activities of animals that displayed discrete 
seizures but did not progress into SE (Sz-NOSE) were also analyzed. (*** denotes 
p<0.001 compared to control maximal values) 
Control 10min 20min 40min 70min Sz-NOSE 
Prolonged SE results in increased PKA activity in cortical homogenates 
Figure 2B. Prolonged SE results in maintenance of PKA activity in hippocampal 
homogenates. 
Hippocampal homogenates were studied for basal (white bars) and maximally 
stimulated kinase activity (black bars) in control, 10,20,40 and 70-minute animals post 
first discrete seizure. In all samples a statistically significant CAMP-induced PKA 
activity was observed compared to basal phosphorylation levels (p<0.001, one-way 
ANOVA). There was no SE-induced effect on basal PKA activity at any time point 
studied. Hippocampal homogenates displayed the same relative trend in increasing PKA 
activity for maximally stimulated samples, however, none of these changes were 
significantly different from control activity. PKA activities for animals that displayed 
discrete seizures but did not progress into SE (Sz-NOSE) were also analyzed. 
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Prolonged SE results in maintenance of PKA activity in hippocampal homogenates 
Figure 3A. SE did not result in an altered PKA catalytic subunit expression in 
cortical homogenates. 
Western blot analysis was used to determine if the SE-induced increase in PKA 
activity was due to an increase in the catalytic subunit (42kD) expression. Figure 3A 
shows cortical homogenate samples for control, 20,40 and 70-minute time points. As the 
blot indicates, there is no significant difference between control and seizure rats for any 
time point studied. 
SE did not result in an altered PKA catalytic subunit expression in cortical 
homogenates 
Figure 3B. SE did not result in significantly altered PKA catalytic subunit 
expression in cortical homogenates. 
Slight variations between control and SE animals were observed for PKA 
catalytic subunit expression in cortical homogenates. However, none of these changes 
were statistically significant when compared to control, nor were they significant when 
compared to one another (n=4 for all samples). This demonstrates that the increase in 
PKA activity observed in cortical homogenate is not due to an increase in catalytic 
subunit expression. 
Control 20 min 40 min 70 min 
SE did not result in significantly altered PKA catalytic subunit expression in 
cortical homogenates 
Figure 3C. SE did not induce a decrease in PKA regulatory subunit expression in 
cortical homogenate. 
Western blot analysis was used to determine if the SE-induced increase in PKA 
activity was due to a relative decrease in PKA regulatory subunit (52kD) expression. 
Cortical homogenate samples for control, 20,40 and 70-minute animals are shown here. 
The blot indicates that there is no significant difference in regulatory subunit expression 
between control and any time point studied. 
SE did not induce a decrease in PKA regulatory subunit expression in cortical 
homogenates 
Figure 3D. SE did not result in significantly altered PKA regulatory subunit 
expression in cortical homogenate. 
No statistically significant differences in PKA regulatory subunit expression were 
observed between control samples and any of the time points studied (n=4 for all 
samples). This indicates that a loss of regulatory subunit expression is not the cause of 
the increased PKA activity. 
Control 20 min 40 min 70 min 
SE did not result in significantly altered PKA regulatory subunit expression in 
cortical homogenate 
Figure 4A. SE did not result in altered PKA catalytic subunit expression in 
hippocampal homogenate. 
Western blot analysis was used to determine if SE-induced maintenance of PKA 
activity was due to an increase in PKA catalytic subunit expression. This figure shows 
hippocampal homogenate samples for control 20,40 and 70-minutes time points. This 
blot indicates that there was no significant difference between control and seizure rats for 
any of the time points studied. 
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SE did not result in altered PKA catalytic subunit expression in hippocampal 
homogenate 
Figure 4B. SE did not result in significantly altered PKA catalytic subunit 
expression in hippocampal homogenate. 
While there is an apparent trend towards decreasing levels of PKA catalytic 
subunit expression in hippocampal homogenates, there was no statistical significance 
between control and any time point studied. This shows that, while there was no increase 
in PKA activity in these samples, there was no significant change in the level of protein 
expression either. (n=4 for all samples) 
Control 20min 40min 70min 
SE did not result in significantly altered PKA catalytic subunit expression in 
hippocampal homogenate 
Figure 4C. SE did not result in altered PKA regulatory subunit expression in 
hippocampal homogenate. 
Western blot analysis was used to determine if the maintenance of PKA activity 
during SE seen in hippocampal homogenate was due to a decreased expression of PKA 
regulatory subunits. This blot shows hippocampal homogenate samples for control, 20, 
40 and 70-minute animals. Probing for PKA regulatory subunits indicates that there is no 
significant difference between control samples and any time point studied. 
SE did not result in significantly altered PKA regulatory subunit expression in 
hippocampal homogenate 
Figure 4D. SE did not result in significantly altered PKA regulatory subunit 
expression in hippocampal homogenate. 
Presented here is a graphical representation of PKA regulatory subunit protein 
levels represented in the previous western blot. While a trend towards decreasing protein 
expression is noticed, none of the time points studied displayed a significant difference 
from control. (n=4 for all samples) 
Control 20 min 40 min 70 min 
SE did not result in significantly altered PKA regulatory subunit expression in 
hippocampal homogenate 
Figure 5A. Prolonged SE results in increased PKA activity in cortical crude SPM 
fractions. 
Cortical crude synaptic membrane (crude SPM) fractions were studied for basal 
levels (white bars) and maximally stimulated (black bars) levels of PKA activity in 
Control, 10,20,40 and 70-minute animals. There was no SE-induced effect on basal 
activity levels. All samples showed a significant increase in PKA activity between basal 
and CAMP stimulated samples (p<0.001, one-way, ANOVA). PKA activity was 
maintained over the early stages of SE in the cortex but displayed a significant increase in 
activity at 40-minutes (* represents statistical significance of p<O.O5 when compared to 
control maximal values). An increase was also noted at 70-minutes but this was not 
significant. 
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Prolonged SE results in increased PKA activity in cortical crude SPM fractions 
Figure 5B. SE results in maintenance of PKA activity in hippocampal crude SPM 
fractions. 
Hippocampal homogenates were studied for basal (white bars) and maximally 
stimulated kinase activity (black bars) in control, 10,20,40 and 70-minute animals post 
first discrete seizure. In all samples, a statistically significant CAMP-induced PKA 
activity was observed compared to basal phosphorylation levels (p<0.001, one-way 
ANOVA). There was no SE-induced effect on basal PKA activity at any time point 
studied. Hippocampal homogenates displayed the same relative trend in increasing PKA 
activity for maximally stimulated samples; however, none of these changes were 
significantly different from control activity. 
Control 10min 20min 40min 
SE results in maintenance of PKA activity in hippocampal crude SPM fractions 
Figure 6A. SE results in differential effects on PKA catalytic subunit expression in 
cortical crude SPM fractions. 
To determine if an increase in PKA catalytic subunit expression was responsible 
for the SE-induced increase in PKA activity in cortical crude SPM fractions, western blot 
analysis was performed. This blot shows cortical Crude SPM fractions for control, 20,40 
and 70-minute animals. PKA catalytic subunit expression remains relatively stable in the 
20 and 70-minute samples. Interestingly, there is a 75% decrease in catalytic subunit 
expression at 40-minutes. This decrease in protein expression combined with the 
observed increase in kinase activity at the same time point indicates that PKA activity is 
significantly altered during the course of SE. 
SE results in differential effects on PKA catalytic subunit expression in cortical 
crude SPM fractions 
Figure 6B. Late stages of SE result in differential effect8 on PKA catalytic subunit 
expression in cortical crude SPM fractions. 
PKA catalytic subunit expression in 20 and 70-minute samples is shown to 
experience no significant change when compared to control. 40-minute samples, 
however, show a statistically significant 75% decrease in expression of catalytic subunits 
(All n=4 and * denotes p<0.05). To ensure that this result was not due to protein loading 
error, blots were probed for P-tubulin. No differences were noted in P-tubulin expression 
for any time point studied. This confirms the decreased PKA concentration to be an 
accurate result. The return to near control values at 70-minutes indicates that there could 
be some form of PKA translocation away from the synapse at 40-minutes with a 
subsequent return of protein. Degradation and synthesis of new proteins should not be 
ruled out however. 
Control 20 min 40 min 70 min 
Late stages of SE result in differential effects on PKA catalytic subunit expression in 
cortical crude SPM fractions 
Figure 6C. SE results in differential effects of PKA regulatory subunit expression in 
cortical crude SPM fractions. 
To determine if a decrease in PKA regulatory subunit expression was responsible 
for the SE-induced increase in PKA activity in cortical crude SPM fractions, western blot 
analysis was performed. This blot shows cortical Crude SPM fractions for control, 20,40 
and 70-minute animals. PKA catalytic subunit expression remains relatively stable in the 
20 and 70-minute samples. Similar to the results seen for catalytic subunit expression, 
there is a 45% decrease in regulatory subunit expression at 40-minutes. 
SE results in differential effects on PKA regulatory subunit expression in cortical 
crude SPM fractions 
Figure 6D. Late stages of SE result in differential effects on PKA regulatory 
subunit expression in cortical crude SPM fractions. 
This figure shows that PKA regulatory subunit expression is maintained, 
compared to control, in 20 and 70-minute samples. Similar to the results seen for 
catalytic subunits, PKA regulatory subunit expression is observed to decrease at 40- 
minutes. This decrease (45%) is not significant when compared to control and is smaller 
than the decrease associated with catalytic subunits. Here too, the results suggest either a 
translocation of PKA away from the synapse with a subsequent return or the possibility 
of protein degradation and then synthesis. 
Control 20 min 40 min 70 min 
Late stages of SE result in differential effects on PKA regulatory subunit expression 
in cortical crude SPM fractions 
Figure 7A. Prolonged SE does not result in altered PKA, catalytic subunit 
expression in hippocampal crude SPM fractions. 
To determine if any alterations in PKA catalytic subunit expression were 
observed in hippocampal crude SPM fractions, western blot analysis was performed. 
Samples from control, 20,40 and 70 minute samples showed no significant differences in 
levels of catalytic subunit expression when compared between one another. 
Prolonged SE does not result in altered PKA catalytic subunit expression in 
hippocampal crude SPM fractions 
Figure 7B. Prolonged SE does not result in significantly,altered PKA catalytic 
subunit expression in hippocampal crude SPM fractions. 
While there were some minor variations in PKA catalytic subunit expression in 
cortical crude SPM between control samples and each time point tested, none were 
significant. This data mirrors the findings that PKA activity is maintained but does not 
increase in these fractions. 
Control 20 min 40 min 70 min 
Prolonged SE does not result in altered PKA catalytic subunit expression in 
hippocampal crude SPM fractions 
Figure 7C. SE does not result in altered PKA regulatory subunit expression in 
hippocampal crude SPM fractions. 
Western blot analysis was used to determine if any changes in expression of PKA 
regulatory subunits occurred in hippocampal crude SPM during SE. Comparing samples 
from control, 20,40 and 70-minute animals indicated that there was no significant change 
in protein expression. 





SE does not result in altered PKA regulatory subunit expression in hippocampal 
crude SPM fractions 
Figure 7D. SE does not result in significantly altered PKA regulatory subunit 
expression in hippocampal crude SPM fractions. 
There was some variation in expression of PKA regulatory subunits in 
hippocampal crude SPM fractions. However, no statistically significant differences were 
noted between control samples and samples from any time point studied. This data 
indicates that during the progression of SE, PKA expression is not significantly altered in 
the hippocampus. 
Control 20 min 40 min 70 min 
SE does not result in significantly altered PKA regulatory subunit expression in 
hippocampal crude SPM fractions 
DISCUSSION 
Through electrographic mapping of seizure progression in the Pilo-SE model this 
study demonstrated an increase in PKA activity without an increase in total PKA protein. 
This suggests some form of post-translational modification occurring during the 
progression of SE which results in a dramatic increase in kinase activity. The results also 
showed a delayed increase in synaptic PKA activity over the progression of SE. This 
increase in activity was also not associated with an increase in protein concentration. 
Since prolonged seizure activity observed in SE has been shown to induce spontaneous 
recurrent seizures (SRS), the increase in PKA activity associated with late stages of SE 
could play a role in the development of these recurrent epileptic seizures. These 
observations suggest that these changes could lead to more permanent changes associated 
with seizure disorders. 
One possible outcome from the cellular changes seen in SE is an imbalance in the 
regulation of membrane excitability. It has been shown previously that total CaMKII 
activity decreases significantly coincident with the onset of SE (Singleton et al. 2005a). 
In addition there is an early maintenance of PKA activity during SE with a subsequent 
increase in activity at later stages. This results in a change in regulation of a variety of 
cellular proteins. For example, CaMKII has been shown to positively regulate the 
function of GABAA receptors causing increased inhibitory currents (Wang et al. 1995), 
and increased agonist (Churn and DeLorenzo 1998) and allosteric modulator binding 
(Churn et al. 2002). At the same time, PKA has been shown to inhibit GABAA receptor 
channel function depending on the subunit composition (Kapur and Macdonald 1996). 
Together, these changes in CaMKII and PKA activities would result in a decreased 
GABAergic inhibitory input thus creating an imbalance the regulation of membrane 
excitability. This data is mirrored by the findings that there is a complete loss of 
benzodiazepine efficacy during SE which act primarily on GABAergic receptors. 
Another outcome of the differential regulation of CaMKII and PKA is in the function of 
cyclic-AMP response element binding protein (CREB). Both PKA and CaMKII have 
been shown to phosphorylate CREB at Ser-133 (Shaywitz and Greenberg 1999). This 
activates the protein allowing for entry into the nucleus to induce gene transcription. At 
the same time CaMKII has been shown to phosphorylate an additional site on CREB, 
Ser- 142, resulting in the inhibition of the enzyme (Dash et al. 199 1 ; Sheng et al. 199 1 ; 
Sun et al. 1994). Thus, CaMKII and PKA play antagonistic roles in the function of this 
protein and the subsequent synthesis of new proteins. The observed decrease in total 
CaMKII activity and increased PKA activity seen in SE could result in the net activation 
of CREB, thereby allowing for gene transcription and new protein synthesis. Support for 
this could lie in the apparent translocation of PKA away from the synapse seen after 40 
minutes of SE. It is possible that PKA leaves the synapse and moves out into the 
cytoplasm where the majority of CREB is located. Further studies will be required to 
determine if there is an increased level of CREB phosphorylation and if a detectable 
increase in PKA protein is noticed in other subcellular fractions at this time. 
An alternative hypothesis is that the cellular changes seen in the Pilo-SE model 
represent a pathological extension of long-term potentiation (LTP). Formation of LTP 
has been shown to be dependent on the actions of CaMKII and PKA. CaMKII activation 
has been shown to be required for the induction of early stages of LTP (Barria et al. 1997; 
Chen et al. 2001; Lisman et al. 2002; Soderling and Derkach 2000). This increase in 
activity results in an increased phosphorylation levels of a-amino-3-hydroxy-5-methyl-4- 
isoxazoleproppionate (AMPA) receptors causing an increase in receptor function. This 
leads to altered membrane excitability and plasticity changes. Other factors are required 
to make the plasticity changes and alterations in membrane excitability more permanent. 
Progression into later stages of LTP has been shown to be dependent on an increase in 
PKA activity (Duffy and Nguyen 2003; Huang et al. 2000; Matsushita et al. 2001). This 
progression into late-LTP involves, among other events, an increase in neurotransmitter 
release (Kuromi and Kidokoro 2000; Thakur et al. 2004), increased ion channel insertion 
(Crump et al. 2001; Esteban et al. 2003), increased ion channel conductance (Meuth et al. 
2002) and new protein synthesis (Kang and Schuman 1996; Krug et al. 1984; Otani et al. 
1989). This shows that through multiple tetanic stimulations synapses can be selectively 
potentiated and progress from a state of learning to one of memory consolidation. 
It is possible that the multiple discrete seizures and subsequent prolonged seizure 
activity in the Pilo-SE model represent a pathological extension of synaptic LTP. In this 
analogy, the expression of discrete seizure activity would act like whole-brain tetanic 
stimulation. This would result in increased CaMKII activity and induce prolonged 
seizure activity. Thus resulting in increased PKA activity leading to maintenance of a 
prolonged increase in membrane excitability. CaMKII activity in the synapse has been 
shown to increase coincident with the onset of SE (Singleton et al. 2005a). As seizure 
activity progresses, we have observed a significant increase in synaptic and total PKA 
activity. These discrete seizures could represent the tetanic stimuli that are required for 
the formation of LTP in synapses and single cells. However, instead of potentiating a 
single cell or synapse, discrete seizures would potentiate all of the synapses of a given 
brain region. 
If these changes result in the potentiation of thousands of synapses across whole 
brain regions, it could lead to the formation of a whole brain LTP-like event. This would 
result in the synchronization of the synapses and result in thg formation of seizures. SE 
has been shown to be an ideal model for use in inducing epileptogenesis (Rice and 
DeLorenzo 1998; Turski 2000). Epileptogenesis is the process by which individuals 
develop spontaneous recurrent seizures (SRSs). Since SRSs have been shown to occur 
following SE and the data here show that changes associated with the formation of LTP 
also occur during SE, there is a possibility that SE results in the formation of a whole 
brain LTP-like event. The progression from early stages of SE to late stages with 
accompanying cellular changes could cement alterations in membrane excitability across 
the entire brain. This would result in an increased occurrence of spontaneous seizures 
referred to as epilepsy. 
An additional point of interest is the relationship between the changes in PKA 
activity and the progression of the seizure profile seen in the Pilo-SE model. While PKA 
activity is maintained during the early phases of SE, PKA activity increases roughly 
coincident with the onset of the FSP  phase of SE. This indicates that a large-scale PKA 
activity change could either push the seizure progression into later stages or prevent SE 
activity from reverting back to earlier, less pathological phases. To further analyze this 
relationship, PKA activity should be studied in those animals that do not enter the later 
seizure profile stages of SE. It has been shown that young rats (postnatal day 30) are 
much less likely to enter late phases of SE primarily progressing only to the EC phase 
(Holbert I1 et al. 2004). In addition, younger animals have also been shown to be less 
likely to develop spontaneous recurrent seizures following SE than older animals (Sankar 
et al. 2000). If no increase in PKA activity after 40 minutes of SE is noticed in these 
animals, it could indicate that the increase in PKA activity seen in adult animals may 
have a causative effect on the progression through late stages of SE. This would provide 
further evidence that SE treatments targeted towards PKA could have a positive impact 
on reducing seizure severity and possibly reduce the occurrence of spontaneous recurrent 
seizures. 
The findings in this paper characterize both the EEG and phosphorylation studies 
of a time dependent SE-induced increase in PKA activity. During early periods of SE, 
when total CaMKII activity is observed to decrease, PKA activity is maintained. Later in 
the progression of SE, PKA activity is observed to increase significantly. This indicates 
that PKA could provide a neuronal marker for the development of later, more 
pathological stages of SE and possibly give an indication as to susceptibility of 
epileptogenesis. In addition to the increase in PKA activity seen in both the homogenate 
and crude SPM samples, there is no associated increase in PKA protein levels. This 
indicates that the increase in PKA activity is the result of some yet to be determined post- 
translational modification mechanism. 
DISCUSSION 
PKA changes associated with late stages of status epilepticus 
This study was performed to examine the relationship between PKA activity and 
the development of status epilepticus (SE). Previously our lab has shown that coincident 
with the onset of SE, there is an immediate decrease in CaMKII activity on a whole cell 
level (Singleton et al. 2005a). Because it has been shown that CaMKII positively 
modulates the function of GABAergic receptor function (Churn and DeLorenzo 1998; 
Churn et al. 2002; Wang et al. 1995), a decrease in CaMKII activity may result in 
decreased inhibitory neuronal signaling. At the same time, it is known that PKA can also 
cause the inhibition of GABAergic receptors depending on subunit composition (Kapur 
and Macdonald 1996; Tehrani and Barnes 1995). Taken together, loss of CaMKII 
activity and either maintenance or an increase in PKA activity would result in the 
alteration of normal neuronal membrane excitability as is seen in seizure states. It was 
our hypothesis that during SE PKA activity is maintained to offset the decrease in total 
CaMKII activity thus resulting in altered regulation of membrane excitability. The 
results from this study indicate that not only is PKA activity maintained during the early 
stages of SE, there is an appreciable increase in PKA activity during later stages of SE 
progression. This interesting finding could be significant for a variety of reasons 
including a possible link between the developmental progression of SE and the induction 
of stages of long-term potentiation (LTP). 
This study showed that in the rat pilocarpine model of SE, PKA activity is 
maintained during approximately the first 20-30 minutes of seizure activity. Following 
this time there is a significant increase in the level of PKA activity in cortical whole 
tissue homogenates. Hippocampal samples showed a similar trend but did not reach 
significance in total PKA activity. Western blot analysis of cortex and hippocampal 
homogenates revealed no significant change in PKA subunit expression (either catalytic 
or regulatory) in any of the time points studied. This indicates that synthesis of new PKA 
protein is not responsible for the increase in kinase activity., 
PKA activity assays in cortical crude synaptic fractions displayed results similar 
to those seen in the homogenate samples. Cortical crude SPM activity was observed to 
remain at control levels during the initial stages of SE. After 40-minutes of seizure 
activity, however, PKA activity is shown to increase significantly. Western analysis of 
crude synaptic fractions revealed slightly different results than those seen in the 
homogenate. PKA protein concentration for both catalytic and regulatory subunits 
remained relatively constant for early periods of SE. After 40 minutes of seizure activity, 
however, there is a significant decrease in protein concentration in the cortical synaptic 
fractions. This decrease appears transient due to the return of PKA protein levels to near 
control values after 70 minutes of seizure activity. PKA activity and protein 
concentration in hippocampal samples were maintained at near control levels for all time 
points studied. The data indicate that late stages of SE result in increased activation of 
PKA through some form of post-translational modification mechanism and also suggest 
that there is some level of PKA translocation away from the synapse. Combined with the 
fact that CaMKII activity decreases at the onset of SE, these data indicate that the cellular 
changes observed during SE could lead to improper regulation of membrane excitability. 
LTP - SE relationship 
Another hypothesis for the cellular changes associated with SE involves the 
formation of long-term potentiation. Extensive research has shown that CaMKII and 
PKA activation are required for the formation of different stages of LTP (Huang and 
Kandel 1994; Wikstrom et al. 2003; Yang et al. 2004). In early stages of SE, CaMKII is 
responsible for the positive modulation of AMPA receptor qhannels. Activated via ca2' 
influx through N-methyl-D-aspartate receptor channels (NMDA), CaMKII 
phosphorylates AMPA receptors resulting in increased channel function and the 
induction of LTP (Derkach et al. 1999; Soderling and Derkach 2000). Formation of later 
stages of LTP has been shown to be dependent primarily on new protein synthesis which 
is accomplished through a PKA dependent mechanism (Frey et al. 1988; Nguyen et al. 
1994; Woo et al. 2002). PKA works to maintain early stages of LTP through reversible 
phosphorylation of membrane ion channels and triggers synthesis of new proteins 
through phosphorylation of transcription factors such as cyclic-AMP response element 
binding protein (CREB). This leads to the transcription of genes and the eventual 
translation of mRNA into proteins. This has been shown to be especially prevalent in 
dendritic spines during late-LTP, although the mechanism and identity of translated 
mRNAs is still largely unresolved (Frey et al. 1988; Nguyen et al. 1994; Tsokas et al. 
2005; Woo and Nguyen 2003). The combination of the increased CaMKII and PKA 
activities results in the strengthening of synaptic signaling. This results in synapses 
converting from a state of learning to one of memory consolidation. 
In light of the fact that both CaMKII and PKA show an increase in synaptic 
activity during the formation of LTP as well as in the Pilo-SE model, it makes one 
wonder if there is a relationship between the two and if SE could be a pathological 
extension of LTP. High frequency stimulations have been shown to induce LTP through 
the activation of CaMKII in neurons (Fukunaga et al. 2002; Fukunaga et al. 1995; Havik 
et al. 2003). In an analagous manner, CaMKII activity is observed to increase in synaptic 
fractions coincident with the onset of SE. SE is typically preceded by a series of 2-3 
discrete seizures. These seizures are brief, 10-50 seconds, and contain high amplitude 
spiking (Singleton et al. 2005b). When repeated, these discrete seizures could be acting 
to stimulate CaMKII activation on a whole-brain level in the same manner as high 
frequency stimulation of synapses in LTP paradigms. Interestingly animals that 
experience discrete seizures, but fail to enter into SE do not display a change in either 
CaMKII or PKA activity. This could suggest that either a certain severity of discrete 
seizure is required for the increase in CaMKII activity or that CaMKII activity increases 
as a result of the transformation from discrete seizures to the continuous seizure activity 
of SE. In addition this study shows that PKA activity increases after prolonged seizure 
activity and after the increase in CaMKII activity subsides. This increase in PKA activity 
could lead to the synthesis of new proteins required for the induction of later stages and 
maintenance of LTP. SE has been shown to be an accurate model to induce 
epileptogenesis (Rice and DeLorenzo 1998; Turski 2000). Due to this, the occurrence of 
discrete seizures followed by an increase in CaMKII and PKA activities could result in 
the transformation of SE into a potentiated seizure condition, epilepsy, in an LTP-like 
manner. 
Possible cellular changes associated with SE 
During SE there are many changes occurring within neurons producing a myriad 
of cellular alterations. Included in these are changes in the activity levels of several 
protein kinases and phosphatases, notably, CaMKII, PKA and calcineurin (CaN). 
Coincident with the onset of SE, total CaMKII activity is observed to decrease while 
synaptic activity increases before decreasing over time (Singleton et al. 2005a). This can 
result in a variety of changes in the cell. CaMKII has been shown to pl~ospl~orylate 
AMPA receptors at the Ser-83 1 site. This causes a positive regulation of ion influx 
through these channels resulting in increased inward ~ a +  and ca2+ currents. Activation 
of CaMKII has also recently been shown to transiently phosphorylate the translation 
factor cytoplasmic polyadenylation element binding protein (CPEB) (Atkins et al. 2005). 
This results in new protein synthesis including new dendritic spine formation. If 
CaMKII activation is not sustained however, this activation of CPEB is lost after a short 
time (Atkins et al. 2005). In addition, CaMKII has been shown to phosphorylate CREB 
(primariy associated with PKA) at two sites and is traditionally thought to inhibit CREB 
function (Dash et al. 1991 ; Sheng et al. 1991 ; Sun et al. 1994). Loss of CaMKII activity 
would disinhibit CREB thus allowing it to take over for the now inactivated CPEB. 
Since loss of CaMKII is seen during the progression of SE, membrane excitability and 
new protein synthesis must be regulated in other ways. An increase in PKA activity seen 
at later stages of SE is a plausible option. 
PKA has been shown to cause an increase in protein synthesis and increased 
membrane excitability in a variety of ways. First, PKA's main path to protein synthesis 
is through the phosphorylation of CREB. This allows CREB to enter the nucleus, bind 
CRE sites, and initiate gene transcription. PKA can also affect the CaMKII activation of 
CPEB, by maintaining its level of phosphorlyation. Normally CPEB is dephosphorylated 
by protein phosphatase 1 (PP1). PKA acts to inhibit PP1 through the activation of 
dopmanine and CAMP-regulated phosphoprotein -32 (DARPP-32) and inhibitor 1. 
Activation of this family of proteins causes the inhibition of PP1 resulting in a 
maintenance of phosphorylation of CPEB. This mechanism is also responsible for 
maintaining the activation of AMPA receptors regulated through phosphorylation by 
CaMKII (Vinade and Dosemeci, 2000). These two events result in an increase in ion 
conductance as well as new protein synthesis. 
In addition to the SE-induced changes in CaMKII and PKA activity, there are 
significant changes observed in protein phospliatase 2B or calcineurin (CaN). CaN has 
been associated with the modulation of function of both GABA and NMDA receptors 
(Huang and Dillon 1998; Krupp et al. 2002; Lu et al. 2000; Umemiya et al. 2001) and is 
also involved in regulating the release of neurotransmitters (Cordeiro et al. 2000), gene 
transcription (Clipstone and Crabtree 1992; Jain et al. 1993) and cytoskeletal architecture 
(Drewes et al. 1993; Goto et al. 1985; Mandelkow et al. 1995). Roughly coincident with 
the increase in PKA activity, CaN activity is observed to increase in both basal and 
maximal reactions (Kurz et al. 2001). This increase has several effects within the cell. 
First, CaN causes the activation of cofilin which leads to actin depolymerization in 
dendritic spines (Wang et al. 2005). This is often seen in neuronal degeneration 
associated with traumas such as seizures. In addition, CaN acts to reduce AMPA 
receptor ion conductance through the disinhibition of PP1. This is in direct contrast to 
the action of PKA on PP1. Since seizures are observed to continue after this 30-40 
minute time point, PKA activity could overpower that of CaN and cause the continued 
excitation of glutamatergic receptor function. CaN also plays a role in the regulation of 
new protein synthesis. CaN is able to inactivate CREB through the disinhibition of PP1, 
however, this only occurs following weakly stimulated synapses and cells (Hagiwara et 
al. 1992; King et al. 1984). It has also been reported that inhibition of CaN results in the 
enhancement of learning and memory and LTP (Malleret et al. 2001). This indicates that 
the increase in CaN activity seen during SE progression could be an attempt to reduce the 
long term effects of the seizures which are possibly caused through a PKA dependent 
mechanism. 
Regulation of PKA activity 
Regulation of PKA activity .through NMDA receptor mediated ca2+ entry is 
complex. ca2+ can cause the activation of adenylate cyclases resulting in the formation 
of cAMP which leads to the activation of PKA. At the same time, this influx of ca2' can 
lead to the activation of calmodulin dependent phosphodiesterases (PDEs) which leads to 
a decrease in cAMP levels. This phenomenon is counterbalanced through the activation 
of CaMKII which inhibits the PDEs (Hashimoto et al. 1989). Since CaMKII activity is 
observed to decrease early in SE progression it is unlikely that this mechanism is what 
maintains PKA activity during the later stages of SE. Further reports suggest that PKA 
can be autoregulated. Activation of PKA can lead to phosphorylation of the regulatory 
subunits by the catalytic subunits thereby reducing their binding affinity (First et al. 
1988). Attempts were made during this study to look at the levels of PKA regulatory 
subunit phosphorylation, however, no reliable results were ever obtained. Additionally, it 
has been shown that there is selective degradation of PKA regulatory subunits through 
ubiquitination (Chain et al. 1999; Chain et al. 1995; Hegde et al. 1993; Hegde et al. 
1997). This results in the reduction of the regulatory to catalytic subunit ratio which 
would lead to prolonged activation. This is plausible considering the decrease in PKA 
regulatory subunit expression seen in the crude SPM after 40-minutes of SE, but does not 
explain the return to control levels at 70-minutes. Further studies are required to 
determine if the PKA protein is translocating away from the synapse then back between 
40 and 70-minutes or, alternatively, if the protein is being degraded by some mechanism 
and then resynthesized. , 
The cellular changes listed here are but a few of the many effects that these 
kinases and phosphatases have on the cell at any given time. Further research is required 
to fully elucidate the relationship between all of these enzymes and the impact that the 
progression of SE has on each. 
Future Areas of Research 
To date there has been little research that focuses on the role PKA plays in the 
progression of SE and its affect on the formation of spontaneous recurrent seizures. This 
study focuses on a temporal relationship between SE progression and PKA activity in 
adult animals. The data suggest that the significant increase in PKA activity could result 
in further progression through SE and that PKA may play a role in the formation of more 
permanent seizure states. In light of this, there are several additional areas of interest for 
future study. 
The PKA activity assays used in this study employed an exogenous substrate. To 
characterize more thoroughly the effects of the increased PKA activity, a variety of 
endogenous substrates could be observed for changes in phosphorylation level during the 
progression of SE. For example, new protein synthesis has been shown to be required for 
the induction and maintenance of late-LTP (Huang et al. 2000). This is a PKA dependent 
process acting through cyclic-AMP response element binding protein (CREB). An 
increase in the level of phospho-CREB at late stages of SE would provide further 
evidence that the increase in PKA activity is playing a role in the long-term maintenance 
of a pathological extension of LTP. Phospho-CREB specific antibodies are commercially 
available to facilitate this study. At the same time, there are a variety of ion channels that 
are directly or indirectly regulated by PKA. AMPA channels are known to be 
phosphorylated by CaMKII at Ser-83 1. This level of phosphorylation is regulated by the 
action of protein phosphatase 1 (PP 1) which is activated through a disinhibition by 
calcinuerin. PKA regulates this process by phosphorylating Inhibitor l/DARPP-32 
family members which inhibits the activity of PPl (Vinade and Dosemeci 2000). SE 
could produce an increased phospho-inhibitor 1 or phospho-DARPP-32 level which 
would lead to maintained ion currents through AMPA channels and this sustained 
excitability and altered membrane potential. This mechanism would also cause the 
maintenance of CPEB activation, a CaMKII dependent transcription factor, which is 
inactivated via dephosphorylation by PP1. 
Additionally, there are amino acid residues on both AMPA and NMDA channels 
reported to be specific for interaction with PKA. On AMPA channels, Ser-845 is a PKA 
specific site. Phosphorylation at this site causes, by some accounts, increased receptor 
insertion and increased anchoring of the receptor to the postsynaptic density (Vinade and 
Dosemeci 2000). It would be of interest to determine if, during the course of SE, there is 
an increased phosphorylation level of AMPA receptors at the PKA specific site. This 
would give a further causative mechanism for the increased and continued membrane 
excitability associated with prolonged seizures. Furthermore, PKA has been shown to 
increase insertion and clustering of NMDA channels (Crump et al. 2001; Tingley et al. 
1997). Similar to AMPA channels, analysis of phosphorylation levels of NMDA 
channels at PKA specific sites during SE could shed further light on the mechanism 
behind the imbalanced regulation of neuronal membrane excitability. Again phospho- 
AMPA and phospho-NMDA specific antibodies are available for this purpose. 
Conclusions 
This study shows that prolonged episodes of status epilepticus result in an 
increase in protein kinase A activity without the synthesis of significant amounts of new 
PKA protein. This indicates that during SE some form of post-translational modification 
mechanism is occurring that results in the increased activity. This increase in PKA 
activity is subsequent to a decrease in total CaMKII activity and initial increase in 
synaptic CaMKII activity. Decreased total CaMKII activity combined with increased 
PKA activity can lead to an imbalance in membrane excitability regulation as is seen in 
seizure states. An early increase in synaptic CaMKII activity combined with a 
subsequent PKA activity increase in the Pilo-SE model indicates that progression through 
SE could be acting as a pathological extension of LTP. These results support the 
hypothesis that PKA is involved in the progression of SE and may play a role in the 
process of epileptogenesis. 
LITERATURE CITED 
LITERATURE CITED 
Anguelova E, Boularand S, Nowicki JP, Benavides J, Smirnova T. 2000. Up-regulation 
of genes involved in cellular stress and apoptosis in a rat model of hippocampal 
degeneration. J Neurosci Res 59(2):209-2 17. 
Anzai T, Tsuzuki K, Yamada N, Hayashi T, Iwakuma M, Inada K, Kameyama K, Hoka 
S, Saji M. 2003. Overexpression of Ca2+-permeable AMPA receptor promotes 
delayed cell death of hippocampal CAI neurons following transient forebrain 
ischemia. Neurosci Res 46(l):4 1-5 1. 
Atkins CM, Davare MA, Oh MC, Derkach V, Soderling TR. 2005. Bidirectional 
regulation of cytoplasmic polyadenylation element-binding protein 
phosphorylation by Ca2+/calmodulin-dependent protein kinase I1 and protein 
phosphatase 1 during hippocampal long-term potentiation. J Neurosci 
25(23):5604-56 10. 
Bailey CH, Kandel ER. 1993. Structural changes accompanying memory storage. Annu 
Rev Physiol55:397-426. 
Barone P, Parashos SA, Palma V, Marin C, Campanella G, Chase TN. 1990. Dopamine 
D 1 receptor modulation of pilocarpine-induced convulsions. Neuroscience 
34(1):209-217. 
Barria A, Muller D, Derkach V, Griffith LC, Soderling TR. 1997. Regulatory 
phosphorylation of AMPA-type glutamate receptors by CaM-KII during long- 
term potentiation. Science 276(532 l):2042-2045. 
Bassin S, Smith TL, Bleck TP. 2002. Clinical review: status epilepticus. Crit Care 
6(2):137-142. 
Blennow G, Brierley JB, Meldrum BS, Siesjo BK. 1978. Epileptic brain damage: the role 
of systemic factors that modify cerebral energy metabolism. Brain 10 1 (4):687- 
700. 
Bonkale WL, Cowburn RF, Ohm TG, Bogdanovic N, Fastbom J. 1999. A quantitative 
autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein 
kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary 
changes and amyloid deposits. Brain Res 81 8(2):383-396. 
Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram 
quantities of protein utilizing the principle of protein-dye binding. Anal Biochen~ 
72:248-254. 
Butterfield DA, Boyd-Kimball D. 2005. The critical role of methionine 35 in Alzheimer's 
amyloid beta-peptide (1 -42)-induced oxidative stress and neurotoxicity. Biochim 
Biophys Acta 1703(2): 149-1 56. 
Carriedo SG, Sensi SLY Yin HZ, Weiss JH. 2000. AMPA exposures induce mitochondria1 
Ca(2+) overload and ROS generation in spinal motor neurons in vitro. J Neurosci 
20(1):240-250. 
Chain DG, Casadio A, Schacher S, Hegde AN, Valbrun M, Yamamoto N, Goldberg AL, 
Bartsch D, Kandel ER, Schwartz JH. 1999. Mechanisms for generating the 
autonomous CAMP-dependent protein kinase required for long-term facilitation in 
Aplysia. Neuron 22(1): 147-1 56. 
Chain DG, Hegde AN, Yamamoto N, Liu-Marsh B, Schwartz JH. 1995. Persistent 
activation of CAMP-dependent protein kinase by regulated proteolysis suggests a 
neuron-specific function of the ubiquitin system in Aplysia. J Neurosci 
15(11):7592-7603. 
Chen HX, Otmakhov N, Strack S, Colbran RJ, Lisman JE. 2001. Is persistent activity of 
calcium/calmodulin-dependent kinase required for the maintenance of LTP? J 
Neurophysiol 85(4):1368-1376. 
Chetkovich DM, Gray R, Johnston D, Sweatt JD. 1991. N-methyl-D-aspartate receptor 
activation increases CAMP levels and voltage-gated Ca2+ channel activity in area 
CAI of hippocampus. Proc Natl Acad Sci U S A 88(15):6467-6471. 
Churn SB, DeLorenzo RJ. 1998. Modulation of GABAergic receptor binding by 
activation of calcium and calmodulin-dependent kinase I1 membrane 
phosphorylation. Brain Res 809(1):68-76. 
Churn SB, Franks, P.D., Thiessen, M. 2005. Efficacy of Topiramate in Otherwise 
Refractory Status Epilepticus in the Rat. Epilepsia (Revised Manuscript, # 
00682). 
Churn SB, Kochan LD, DeLorenzo RJ. 2000. Chronic inhibition of Ca(2+)/calmodulin 
kinase I1 activity in the pilocarpine model of epilepsy. Brain Res 875(1-2):66-77. 
Churn SB, Limbrick D, Sombati S, DeLorenzo RJ. 1995. Excitotoxic activation of the 
NMDA receptor results in inhibition of calciurn~calmodulin kinase I1 activity in 
cultured hippocampal neurons. J Neurosci 15(4):3200-32 14. 
Churn SB, Rana A, Lee K, Parsons JT, De Blas A, Delorenzo RJ. 2002. 
Calcium/calmodulin-dependent kinase I1 phosphorylation of the GABAA receptor 
alpha1 subunit modulates benzodiazepine binding. J Neurochem 82(5): 1065- 
1076. 
Churn SB, Yaghmai A, Povlishock J, Rafiq A, DeLorenzo RJ. 1992. Global forebrain 
ischemia results in decreased immunoreactivity of calciurn~calmodulin-dependent 
protein kinase 11. J Cereb Blood Flow Metab 12(5):784-793. 
Clipstone NAY Crabtree GR. 1992. Identification of calcineurin as a key signalling 
enzyme in T-lymphocyte activation. Nature 357(6380):695-697. 
Cordeiro JM, Meireles SM, Vale MG, Oliveira CRY Goncalves PP. 2000. Ca(2+) 
regulation of the carrier-mediated gamma-aminobutyric acid release from isolated 
synaptic plasma membrane vesicles. Neurosci Res 3 8(4):3 85-395. 
Crump FT, Dillman KS, Craig AM. 2001. CAMP-dependent protein kinase mediates 
activity-regulated synaptic targeting of NMDA receptors. J Neurosci 
21(14):5079-5088. 
Dash PK, Karl KA, Colicos MA, Prywes R, Kandel ER. 1991. CAMP response element- 
binding protein is activated by Ca2+/calmodulin- as well as CAMP-dependent 
protein kinase. Proc Natl Acad Sci U S A 88(11):5061-5065. 
DeLorenzo RJ, Hauser WAY Towne AR, Boggs JG, Pellock JM, Penberthy L, Garnett L, 
Fortner CA, KO D. 1996. A prospective, population-based epidemiologic study of 
status epilepticus in Richmond, Virginia. Neurology 46(4): 1029- 103 5. 
Derkach V, Barria A, Soderling TR. 1999. Ca2+/calmodulin-kinase I1 enhances channel 
conductance of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate type 
glutamate receptors. Proc Natl Acad Sci U S A 96(6):3269-3274. 
Drewes G, Mandelkow EM, Baumann K, Goris J, Merlevede W, Mandelkow E. 1993. 
Dephosphorylation of tau protein and Alzheimer paired helical filaments by 
calcineurin and phosphatase-2A. FEBS Lett 336(3):425-432. 
Duffy SN, Nguyen PV. 2003. Postsynaptic application of a peptide inhibitor of CAMP- 
dependent protein kinase blocks expression of long-lasting synaptic potentiation 
in hippocampal neurons. J Neurosci 23(4): 1142-1 150. 
Edelman AM, Hunter DD, Hendrickson AE, Krebs EG. 1985. Subcellular distribution of 
calcium- and calmodulin-dependent myosin light chain phosphorylating activity 
in rat cerebral cortex. J Neurosci 5(10):2609-26 17. 
Esteban JA, Shi SH, Wilson C, Nuriya My Huganir RL, Malinow R. 2003. PKA 
phosphorylation of AMPA receptor subunits controls synaptic trafficking 
underlying plasticity. Nat Neurosci 6(2): 136- 143. 
Fink CC, Meyer T. 2002. Molecular mechanisms of CaMKII activation in neuronal 
plasticity. Curr Opin Neurobiol 12(3):293-299. 
First EA, Bubis J, Taylor SS. 1988. Subunit interaction sites between the regulatory and 
catalytic subunits of CAMP-dependent protein kinase. Identification of a specific 
interchain disulfide bond. J Biol Chem 263(1 l):5 176-5 182. 
Fountain NB. 2000. Status epilepticus: risk factors and complications. Epilepsia 41 Suppl 
2:S23-30. 
Frey U, Krug M, Reymann KG, Matthies H. 1988. Anisomycin, an inhibitor of protein 
synthesis, blocks late phases of LTP phenomena in the hippocampal CAI region 
in vitro. Brain Res 452(1-2):57-65. 
Fukunaga K, Horikawa K, Shibata S, Takeuchi Y, Miyamoto E. 2002. Ca2+/calmodulin- 
dependent protein kinase 11-dependent long-term potentiation in the rat 
suprachiasmatic nucleus and its inhibition by melatonin. J Neurosci Res 
70(6):799-807. 
Fukunaga K, Muller D, Miyamoto E. 1995. Increased phosphorylation of 
Ca2+/calmodulin-dependent protein kinase I1 and its endogenous substrates in the 
induction of long-term potentiation. J Biol Chem 270(11):6 1 19-6124. 
Goodkin HP, Liu X, Holmes GL. 2003. Diazepam terminates brief but not prolonged 
seizures in young, naive rats. Epilepsia 44(8): 1 109- 1 1 12. 
Goto S, Yamamoto H, Fukunaga K, Iwasa T, Matsukado Y, Miyamoto E. 1985. 
Dephosphorylation of microtubule-associated protein 2, tau factor, and tubulin by 
calcineurin. J Neurochem 45(1):276-283. 
Hagiwara M, Alberts A, Brindle P, Meinkoth J, Feramisco J, Deng T, Karin M, 
Shenolikar S, Montminy M. 1992. Transcriptional attenuation following CAMP 
induction requires PP- 1 -mediated dephosphorylation of CREB. Cell 70(1): 105- 
113. 
Handforth A, Treiman DM. 1995a. Functional mapping of the early stages of status 
epilepticus: a 14C-2-deoxyglucose study in the lithium-pilocarpine model in rat. 
Neuroscience 64(4): 1057- 1073. 
Handforth A, Treiman DM. 1995b. Functional mapping of the late stages of status 
epilepticus in the lithium-pilocarpine model in rat: a 14C-2-deoxyglucose study. 
Neuroscience 64(4): 1075-1089. 
Hashimoto Y, Sharma RK, Soderling TR. 1989. Regulation of Ca2+/calmodulin- 
dependent cyclic nucleotide phosphodiesterase by the autophosphorylated form of 
Ca2+/calmodulin-dependent protein kinase 11. J Biol Chem 264(18): 10884-10887. 
Havik B, Rokke H, Bardsen K, Davanger S, Bramham CR. 2003. Bursts of high- 
frequency stimulation trigger rapid delivery of pre-existing alpha-CaMKII mRNA 
to synapses: a mechanism in dendritic protein synthesis during long-term 
potentiation in adult awake rats. Eur J Neurosci 17(12):2679-2689. 
Hawkins RD, Kandel ER, Siegelbaum SA. 1993. Learning to modulate transmitter 
release: themes and variations in synaptic plasticity. Annu Rev Neurosci 16:625- 
665. 
Hegde AN, Goldberg AL, Schwartz JH. 1993. Regulatory subunits of CAMP-dependent 
protein kinases are degraded after conjugation to ubiquitin: a molecular 
mechanism underlying long-term synaptic plasticity. Proc Natl Acad Sci U S A 
90(16):7436-7440. 
Hegde AN, Inokuchi K, Pei W, Casadio A, Ghirardi My chain DG, Martin KC, Kandel 
ER, Schwartz JH. 1997. Ubiquitin C-terminal hydrolase is an immediate-early 
gene essential for long-term facilitation in Aplysia. Cell 89(1): 1 15- 126. 
Holbert I1 WHY Ryan ML, Singleton MW, Lee AT, Baodle-Biber MC, Churn SB. 2004. 
Late stages of neuronal development modulate status epilpeticus characteristics. 
Society for Neuroscience 30: 155.22. 
Huang RQ, Dillon GH. 1998. Maintenance of recombinant type A gamma-aminobutyric 
acid receptor function: role of protein tyrosine phosphorylation and calcineurin. J 
Pharmacol Exp Ther 286(1):243-255. 
Huang YY, Kandel ER. 1994. Recruitment of long-lasting and protein kinase A- 
dependent long-term potentiation in the CAI region of hippocampus requires 
repeated tetanization. Learn Mem 1 (1):74-82. 
Huang YY, Martin KC, Kandel ER. 2000. Both protein kinase A and mitogen-activated 
protein kinase are required in the amygdala for the macromolecular synthesis- 
dependent late phase of long-term potentiation. J Neurosci 20(17):63 17-6325. 
Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao 
A. 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and 
interacts with Fos and Jun. Nature 365(6444):352-355. 
Kandel ER. 2001. The molecular biology of memory storage: a dialogue between genes 
and synapses. Science 294(5544): 1030-1038. 
Kang H, Schuman EM. 1996. A requirement for local protein synthesis in neurotrophin- 
induced hippocampal synaptic plasticity. Science 273(5280): 1402- 1406. 
Kapur J, Macdonald RL. 1996. Cyclic AMP-dependent protein kinase enhances 
hippocampal dentate granule cell GABAA receptor currents. J Neurophysiol 
76(4):2626-2634. 
King MM, Huang CY, Chock PB, Nairn AC, Hemmings HC, Jr., Chan KF, Greengard P. 
1984. Mammalian brain phosphoproteins as substrates for calcineurin. J Biol 
Chem 259(13):8080-8083. 
Krug My Lossner By Ott T. 1984. Anisomycin blocks the late phase of long-term 
potentiation in the dentate gyrus of freely moving rats. Brain Res Bull 13(1):39- 
42. 
Krupp JJ, Vissel B, Thomas CG, Heinemann SF, Westbrook GL. 2002. Calcineurin acts 
via the C-terminus of NR2A to modulate desensitization of NMDA receptors. 
Neuropharmacology 42(5):593-602. 
Kuromi H, Kidokoro Y. 2000. Tetanic stimulation recruits vesicles from reserve pool via 
a CAMP-mediated process in Drosophila synapses. ~ e u r o n  27(1): 133-143. 
Kurz JE, Sheets D, Parsons JT, Rana A, Delorenzo RJ, Churn SB. 2001. A significant 
increase in both basal and maximal calcineurin activity in the rat pilocarpine 
model of status epilepticus. J Neurochem 78(2):304-3 15. 
Lisman J, Schulman H, Cline H. 2002. The molecular basis of CaMKII function in 
synaptic and behavioural memory. Nat Rev Neurosci 3(3): 175- 190. 
Lowenstein DH, Alldredge BK. 1998. Status epilepticus. N Engl J Med 338(14):970-976. 
Lowenstein DH, Bleck T, Macdonald RL. 1999. It's time to revise the definition of status 
epilepticus. Epilepsia 40(1): 120- 122. 
Lu YM, Mansuy IM, Kandel ER, Roder J. 2000. Calcineurin-mediated LTD of 
GABAergic inhibition underlies the increased excitability of CAI neurons 
associated with LTP. Neuron 26(1): 197-205. 
Malleret G, Haditsch U, Genoux D, Jones MW, Bliss TV, Vanhoose AM, Weitlauf C, 
Kandel ER, Winder DG, Mansuy IM. 2001. Inducible and reversible enhancement 
of learning, memory, and long-term potentiation by genetic inhibition of 
calcineurin. Cell 104(5):675-686. 
Mandelkow EM, Biernat J, Drewes G, Gustke N, Trinczek B, Mandelkow E. 1995. Tau 
domains, phosphorylation, and interactions with microtubules. Neurobiol Aging 
16(3):355-362; discussion 362-353. 
Matsushita M, Tomizawa K, Moriwaki A, Li ST, Terada H, Matsui H. 2001. A high- 
efficiency protein transduction system demonstrating the role of PKA in long- 
lasting long-term potentiation. J Neurosci 2 1(16):6000-6007. 
McDonald BJ, Moss SJ. 1997. Conserved phosphorylation of the intracellular domains of 
GABA(A) receptor beta2 and beta3 subunits by CAMP-dependent protein kinase, 
cGMP-dependent protein kinase protein kinase C and Ca2+/calmodulin type II- 
dependent protein kinase. Neuropharnlacology 36(lO): 1377- 1385. 
Meuth S, Pape HC, Budde T. 2002. Modulation of Ca2+ currents in rat thalamocortical 
relay neurons by activity and phosphorylation. Eur J Neurosci 15(10): 1603- 16 14. 
Nguyen PV, Abel T, Kandel ER. 1994. Requirement of a critical period of transcription 
for induction of a late phase of LTP. Science 265(5 175): 1 104- 1 107. 
Nguyen PV, Woo NH. 2003. Regulation of hippocampal synaptic plasticity by cyclic 
AMP-dependent protein kinases. Prog Neurobiol71(6):40 1-437. 
Otani S, Marshall CJ, Tate WP, Goddard GV, Abraham WC. 1989. Maintenance of long- 
term potentiation in rat dentate gyms requires protein synthesis but not messenger 
RNA synthesis immediately post-tetanization. Neuroscience 28(3):5 19-526. 
Poncer JC, Esteban JA, Malinow R. 2002. Multiple mechanisms for the potentiation of 
AMPA receptor-mediated transmission by alpha-Ca2+/calmodulin-dependent 
protein kinase 11. J Neurosci 22(11):4406-4411. 
Racine RJ. 1972. Modification of seizure activity by electrical stimulation. 11. Motor 
seizure. Electroencephalogr Clin Neurophysiol32(3):281-294. 
Rice AC, DeLorenzo RJ. 1998. NMDA receptor activation during status epilepticus is 
required for the development of epilepsy. Brain Res 782(1-2):240-247. 
Sankar R, Shin D, Mazarati AM, Liu H, Katsumori H, Lezama R, Wasterlain CG. 2000. 
Epileptogenesis after status epilepticus reflects age- and model-dependent 
plasticity. Ann Neurol48(4):580-589. 
Sankar R, Shin DH, Liu H, Mazarati A, Pereira de Vasconcelos A, Wasterlain CG. 1998. 
Patterns of status epilepticus-induced neuronal injury during development and 
long-term consequences. J Neurosci 18(20):8382-8393. 
Shaywitz AJ, Greenberg ME. 1999. CREB: a stimulus-induced transcription factor 
activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821- 
861. 
Sheng M, Thompson MA, Greenberg ME. 1991. CREB: a Ca(2+)-regulated transcription 
factor phosphorylated by calmodulin-dependent kinases. Science 
252(5011): 1427-1430. 
Singleton MW, Holbert I1 WH, Lee AT, Bracey JM, Churn SB. 2005a. Modulation of 
CaM Kinase I1 Activity Is Coincident with Induction of Status Epilepticus in the 
Rat Pilocarpine Model. Epilepsia 46(9): 1-12. 
Singleton MW, Holbert I1 WH, Ryan ML, Lee AT, Kurz JE, Churn SB. 2005b. Age 
dependence of pilocarpine-induced status epilepticus and inhibition of CaM 
kinase I1 activity in the rat. Devolepmental Brain Research (In Press, Manuscript 
# BRESD6 1472). 
Soderling TR, Derkach VA. 2000. Postsynaptic protein phosphorylation and LTP. Trends 
Neurosci 23(2):75-80. 
Sun P, Enslen H, Myung PS, Maurer RA. 1994. Differential activation of CREB by 
Ca2+/calmodulin-dependent protein kinases type I1 and type IV involves 
phosphorylation of a site that negatively regulates activity. Genes Dev 
8(21):2527-2539. 
Tanaka K. 2001. Alteration of second messengers during acute cerebral ischemia - 
adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP 
response element binding protein. Prog Neurobiol65(2): 173-207. 
Tehrani MH, Barnes EM, Jr. 1995. Reduced function of gaduna-aminobutyric acidA 
receptors in tottering mouse brain: role of CAMP-dependent protein kinase. 
Epilepsy Res 22(1): 13-2 1. 
Thakur P, Stevens DRY Sheng ZH, Rett-ig J. 2004. Effects of PKA-mediated 
phosphorylation of Snapin on synaptic transmission in cultured hippocampal 
neurons. J Neurosci 24(29):6476-648 1. 
Theodore WHY Porter RJ, Albert P, Kelley K, Bromfield E, Devinsky 0, Sato S. 1994. 
The secondarily generalized tonic-clonic seizure: a videotape analysis. Neurology 
44(8):1403-1407. 
Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, Huganir RL. 
1997. Characterization of protein kinase A and protein kinase C phosphorylation 
of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site- 
specific antibodies. J Biol Chem 272(8):5 157-5 166. 
Tomson T. 2000. Mortality in epilepsy. J Neurol247(1): 15-2 1 
Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, 
Faught E, Calabrese VP, Uthrnan BM, Ramsay RE, Marndani MB. 1998. A 
comparison of four treatments for generalized convulsive status epilepticus. 
Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 
339(12):792-798. 
Tsokas P, Grace EA, Chan P, Ma T, Sealfon SC, Iyengar R, Landau EM, Blitzer RD. 
2005. Local protein synthesis mediates a rapid increase in dendritic elongation 
factor 1A after induction of late long-term potentiation. J Neurosci 25(24):5833- 
5843. 
Turski WA. 2000. Pilocarpine-induced seizures in rodents-- 17 years on. Pol J Pharmacol 
52(1):63-65. 
Umemiya My Chen N, Raymond LA, Murphy TH. 2001. A calcium-dependent feedback 
mechanism participates in shaping single NMDA miniature EPSCs. J Neurosci 
21(1):1-9. 
Vinade L, Dosemeci A. 2000. Regulation of the phosphorylation state of the AMPA 
receptor GluRl subunit in the postsynaptic density. Cell Mol Neurobiol 
20(4):45 1-463. 
Wang JH, Kelly P. 200 1. Calcium-calmodulin signalling pathway up-regulates 
glutamatergic synaptic function in non-pyramidal, fast spiking rat hippocampal 
CAI neurons. J Physiol533(Pt 2):407-422. 
Wang RA, Cheng G, Kolaj M, Randic M. 1995. Alpha-subunit of calcium/calmodulin- 
dependent protein kinase I1 enhances gamma-aminobutyric acid and inhibitory 
synaptic responses of rat neurons in vitro. J Neurophysiol73(5):2099-2 106. 
Wang Y, Shibasaki F, Mizuno K. 2005. Calcium signal-induced cofilin 
dephosphorylation is mediated by Slingshot via calcineurin. J Biol Chem 
280(13): 12683-12689. 
Waterhouse EJ, Vaughan JK, Barnes TY, Boggs JG, Towne AR, Kopec-Garnett L, 
DeLorenzo RJ. 1998. Synergistic effect of status epilepticus and ischemic brain 
injury on mortality. Epilepsy Res 29(3): 175-1 83. 
Wei J, Zhang M, Zhu Y, Wang JH. 2004. Ca(2+)-calmodulin signalling pathway up- 
regulates GABA synaptic transmission through cytoskeleton-mediated 
mechanisms. Neuroscience 127(3):637-647. 
Wikstrom MA, Matthews P, Roberts D, Collingridge GL, Bortolotto ZA. 2003. Parallel 
kinase cascades are involved in the induction of LTP at hippocampal CAI 
synapses. Neuropharmacology 45(6):828-836. 
Woo NH, Abel T, Nguyen PV. 2002. Genetic and pharmacological demonstration of a 
role for cyclic AMP-dependent protein kinase-mediated suppression of protein 
phosphatases in gating the expression of late LTP. Eur J Neurosci 16(10): 1 87 1 - 
1876. 
Woo NH, Nguyen PV. 2003. Protein synthesis is required for synaptic immunity to 
depotentiation. J Neurosci 23(4): 1 125- 1 132. 
Yang HW, Hu XD, Zhang HM, Xin WJ, Li MT, Zhang T, Zhou LJ, Liu XG. 2004. Roles 
of CaMKII, PKA, and PKC in the induction and maintenance of LTP of C-fiber- 
evoked field potentials in rat spinal dorsal horn. J Neurophysiol9 l(3): 1 122- 1 133. 
VITA 
James McLeod Bracey was born July 6, 1978 in Fort Worth, Texas and is an 
American citizen. He graduated from Arlington Heights High School in Fort Worth, 
Texas in 1996. He then attended the University of Richmond in Richmond, Virginia 
where he received a Bachelor of Science degree in May of 2000. Following 
undergraduate work, he worked in the field of clinical neurophysiology in the 
Washington, D.C. area where he gained his Certification in Neurophysiologic 
Intraopterative Monitoring. In August of 2003 he returned to Richmond, Virginia to 
attend Virginia Commonwealth University where he received a Certificate in Anatomy 
and Neurobiology in 2004. At Virginia Commonwealth University he has worked in a 
neurology laboratory and is submitting for publication a paper entitled: Status 
Epilepticus Results in a Duration-Dependent Increased Protein Kinase A Activity in the 
Rat Pilocarpine Model. 
